Pharmafile Logo

Meet OPEN Health and Pharmerit Experts at the World Orphan Drug Virtual USA Congress

August 24, 2020 |  

Join OPEN Health and Pharmerit – an OPEN Health Company at the World Orphan Drug Virtual Congress from August 24-27, 2020, as we present:

Advanced Therapies Commercial: Tuesday, August 25
Succeeding with Star Wars Medicine: Translating the Science and Value of Gene Therapy to Key Stakeholders

Gavin Jones, Director of Rare Disease, OPEN Health

PANEL: Wednesday, August 26
Bridging the Clinical Evidence Gap for Payers – Examining Recent Cases of Real-World Evidence for Reimbursement

Shelby Corman, Real-World Evidence and Data Analytics Lead, Pharmerit

Pink divider

OPEN Health is the only integrated agency that combines the depth of rare disease knowledge with the breath of discipline expertise across medical affairs, commercial, HEOR and market access.

OPEN Health’s Evidence and Access practice is a best in class global HEOR and market access consultancy that specialises in identifying client critical issues and building bespoke integrated solutions to support companies operating in rare disease and improve patient outcomes.

The Patient and Brand Communications practice at OPEN Health combines a deep focus in patient engagement (patient journey mapping and patient support programmes), PR (brand, disease awareness, corporate and internal communications) and advertising.

The Medical Communications practice provides expertise in Medical Affairs content and consultancy, publication planning and management, medical education, and internal training.

In addition to extensive rare disease experience we have delivered projects for over half the advanced therapies that have been launched in the United States and Europe.

Pink divider

Our executive team will be available to speak with you regarding how OPEN Health and Pharmerit can support you in the fight against rare diseases. Contact Gavin Jones today to set up a meeting.

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry

OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry

OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer

OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer

Unlock possibilities: A Medical Affairs strategy fit for the future

Explore the key areas to include in a Medical Affairs strategy and plan that is fit for the future in our latest whitepaper.

OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis

OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis

OPEN Health unites patient engagement experts to transform the patient experience

OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, is bringing together experts in strategic patient innovation and engagement,...

The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease

The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease

OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe

OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe

Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

Embracing the Patient Voice Within Publications

This whitepaper will explore multidisciplinary perspectives on how we can better engage patient communities in publications to optimize the value of their contributions, while navigating any uncertainties and reluctance from...

Navigating the nocebo effect through patient engagement is the key to setting patients up for success

If you're interested in delving deeper into this topic and understanding how patient engagement can effectively navigate the nocebo effect, we invite you to explore our latest whitepaper.